EGFR and KRAS mutations in lung carcinoma: Molecular testing by using cytology specimens

作者: Shahreen Billah , John Stewart , Gregg Staerkel , Su Chen , Yun Gong

DOI: 10.1002/CNCY.20151

关键词: CarcinomaAdenocarcinomaLung cancerBiopsyCytologyFine-needle aspirationPathologyCancerMedicineKRAS

摘要: … cytology diagnoses and EGFR or KRAS mutations in lung carcinoma, further validating the … in lung cancer patients. Sufficient material with satisfactory testing results for EGFR or KRAS …

参考文章(28)
Adi F. Gazdar, Shinichi Toyooka, Kazunori Tsukuda, Mitsune Tanimoto, Masahiro Tabata, Kouichi Ichimura, Masaaki Yano, Toshihide Tsuda, Hisayuki Shigematsu, Hiroshi Date, Kunitoshi Tomii, Nobuyoshi Shimizu, Hiroshi Ueoka, Motoi Aoe, Masaki Tokumo, Katsuyuki Kiura, The Relationship between Epidermal Growth Factor Receptor Mutations and Clinicopathologic Features in Non–Small Cell Lung Cancers Clinical Cancer Research. ,vol. 11, pp. 1167- 1173 ,(2005)
Jenifer L. Marks, Stephen Broderick, Qin Zhou, Dhananjay Chitale, Allan R. Li, Maureen F. Zakowski, Mark G. Kris, Valerie W. Rusch, Christopher G. Azzoli, Venkatraman E. Seshan, Marc Ladanyi, William Pao, Prognostic and Therapeutic Implications of EGFR and KRAS Mutations in Resected Lung Adenocarcinoma Journal of Thoracic Oncology. ,vol. 3, pp. 111- 116 ,(2008) , 10.1097/JTO.0B013E318160C607
Atsushi Horiike, Hideharu Kimura, Kazuto Nishio, Fumiyoshi Ohyanagi, Yukitoshi Satoh, Sakae Okumura, Yuichi Ishikawa, Ken Nakagawa, Takeshi Horai, Makoto Nishio, Detection of epidermal growth factor receptor mutation in transbronchial needle aspirates of non-small cell lung cancer. Chest. ,vol. 131, pp. 1628- 1634 ,(2007) , 10.1378/CHEST.06-1673
S-G. Wu, C-H. Gow, C-J. Yu, Y-L. Chang, C-H. Yang, Y-C. Hsu, J-Y. Shih, Y-C. Lee, P-C. Yang, Frequent epidermal growth factor receptor gene mutations in malignant pleural effusion of lung adenocarcinoma European Respiratory Journal. ,vol. 32, pp. 924- 930 ,(2008) , 10.1183/09031936.00167407
Jin-Yuan Shih, Chien-Hung Gow, Pan-Chyr Yang, EGFR Mutation Conferring Primary Resistance to Gefitinib in Non–Small-Cell Lung Cancer The New England Journal of Medicine. ,vol. 353, pp. 207- 208 ,(2005) , 10.1056/NEJM200507143530217
Zhuang Zuo, Su S Chen, Pranil K Chandra, John M Galbincea, Matthew Soape, Steven Doan, Bedia A Barkoh, Hartmut Koeppen, L Jeffrey Medeiros, Rajyalakshmi Luthra, Application of COLD-PCR for improved detection of KRAS mutations in clinical samples Modern Pathology. ,vol. 22, pp. 1023- 1031 ,(2009) , 10.1038/MODPATHOL.2009.59
P. S. Hammerman, P. A. Janne, B. E. Johnson, Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non–Small Cell Lung Cancer Clinical Cancer Research. ,vol. 15, pp. 7502- 7509 ,(2009) , 10.1158/1078-0432.CCR-09-0189
William Pao, Vincent A Miller, Katerina A Politi, Gregory J Riely, Romel Somwar, Maureen F Zakowski, Mark G Kris, Harold Varmus, Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain PLoS Medicine. ,vol. 2, pp. e73- ,(2005) , 10.1371/JOURNAL.PMED.0020073
Susumu Kobayashi, Titus J. Boggon, Tajhal Dayaram, Pasi A. Jänne, Olivier Kocher, Matthew Meyerson, Bruce E. Johnson, Michael J. Eck, Daniel G. Tenen, Balázs Halmos, EGFR Mutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib The New England Journal of Medicine. ,vol. 352, pp. 786- 792 ,(2005) , 10.1056/NEJMOA044238